s-disease

Documents about s-disease

• Glial Cells in Behavioral and Psychological Symptoms of Alzheimer’s Disease#231276Europe PMC
• Altered central vestibular processing in Parkinson's disease with Pisa syndrome#273329Europe PMC
• Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Screening#230440ClinicalTrials.gov
• Seoul National University Pituitary Disease Cohort Study#290932ClinicalTrials.gov
• Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease#175037ClinicalTrials.gov
• Reblastatin as a neuroprotective agent in temporal lobe epilepsy and excitotoxic conditions of Alzheimer's disease and Parkinson's disease.#223084NCBI PubMed Central
• Bayesian modelling demonstrates clinically relevant heterogeneity in Tau PET patterns in Alzheimer's disease#235003Europe PMC
• Neuronutrition for the Primary Prevention of Alzheimer’s Disease for Women in Perimenopause and Early Menopause#173146Harvard DASH
• Recent Insights Into Alzheimer's Disease: Advances in Pathophysiology and Therapeutic Strategies#161229HAL (France)
• Sociodemographic determinants of Alzheimer’s disease in primary care: evidence from the province of Salamanca (Spain)#283951Gestión del Repositorio Documental de la Universidad de Salamanca
• Rice Leaf Disease Detection and Remedies using Deep Learning#92256PhilArchive
• 2026 Alzheimer's disease facts and figures.#135628NCBI PubMed Central
• Norepinephrine and dopamine Imbalance in the medial frontal gyrus from patients with Alzheimer's disease#5380Europe PMC
• The role of ionotropic glutamate receptors in Alzheimer's disease: A scientometric analysis#5614Europe PMC
• Insight Into the Epigenetics of Alzheimer's Disease: A computational study from Human Interactome#31381Zenodo (CERN)
• Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred#259841Europe PMC
• Analyzing single nuclei transcriptomes of Alzheimer's disease mice model#261747edoc-Server
• Integrating psychotherapy into clinical care for individuals with Parkinson's disease#186557Spiral
• DNA methylation profiling in Huntington's disease reveals disease associated changes in the striatum.#232248NCBI PubMed Central
• Alzheimer's disease in patients prescribed statins: A real-world data analysis of U.S. patient health records#5615Europe PMC
• Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease#4491Europe PMC
• Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association#7091OpenAlex
• What are the top 10 global research priorities for perianal Crohn's disease? The Global Perianal Crohn's Disease Priority Setting Partnership.#151464NCBI PubMed Central
• Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)#216979ClinicalTrials.gov
• Translational Feasibility of Curcumin for Treatment of Alzheimer’s Disease: A Critical Appraisal of Clinical Challenges#231310Europe PMC
• Influence of Speech Disfluencies and Prompt Optimization in LLM-Based Alzheimer's Disease Classification#246121DigitalCommons@Kennesaw State University
• Glial Cells in Behavioral and Psychological Symptoms of Alzheimer's Disease#246391Europe PMC
• Translational Feasibility of Curcumin for Treatment of Alzheimer's Disease: A Critical Appraisal of Clinical Challenges#246393Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data✰✰✰#123242Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data#125809Europe PMC
• Rare Variant Burden Analysis of Dystonia Genes in Parkinson's Disease#154942bioRxiv / medRxiv
• Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease#120130Europe PMC
• Public Policy Implications of Liability Regimes for Injuries Caused by Persons with Alzheimer's Disease#167575Digital Commons @ University of Georgia School of Law
• Spike RBD drives sustained Parkinson's disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation#205505Europe PMC
• Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease#250650IRIS
• AN INVESTIGATION INTO THE NEUROPROTECTIVE POTENTIAL OF ERGOTHIONEINE IN THE AMYLOID HYPOTHESIS OF ALZHEIMER’S DISEASE#254779ScholarBank@NUS
• Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone#262367IRIS
• Low Sensitivity of Neuropsychological Scales Hinder Detection of Potential Benefit of Treatments in Alzheimer's Disease: A Position Paper#5557Europe PMC
• A paradigm of the diagnosis and treatment for the whole process of Alzheimer's disease.#214365PubMed
• D-serine metabolism enhances Escherichia coli fitness in the gut and could contribute to Enterobacteriaceae expansion in Crohn's disease patients#13194HAL (France)
• Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease#182053Europe PMC
• Physical activity and Alzheimer’s disease: a call for evidence incorporation#126826HAL (France)
• An Early Access Program For Ustekinumab In Participants With Moderately To Severely Active Crohn's Disease#160356ClinicalTrials.gov
• Serum amino acid levels are associated with brain hypometabolism in patients across the Alzheimer's disease continuum#5363Europe PMC
• Diagnostic Potential of Combined Skin Morphometric Analysis and Salivary Alpha-Synuclein Oligomers in Parkinson's Disease#120143Europe PMC
• Heterogeneous patterns of cognitive decline in Alzheimer's disease across three domains of cognition#144950HAL (France)
• Screening for Alzheimer's disease in the community using an AI-driven screening platform: design of the PREDICTOM study#182054Europe PMC
• Assessing Naturalistic Communication in Parkinson’s Disease: A Passive Audio Capture Study#186601OSF
• Naphthyl-functionalized acetamide derivatives: Promising agents for cholinesterase inhibition and antioxidant therapy in Alzheimer's disease#197436Repositorio UNAB
• A computational framework to predict the spreading of Alzheimer’s disease#248588Spiral